About 200 reports

EU KEY OPINION LEADER " Capsaicin is one of them, [and] sometimes the Lidocaine patch is used; this is off-label also for these patients.

  • Chronic Disease
  • Forecast
  • Daiichi Sankyo Company
  • Depomed, Inc.
  • Pfizer Inc.

Table ##.

  • Chronic Disease
  • Forecast
  • Mylan Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.

According to the company reports, Fagron' s branches in Europe are situated at the Netherlands (##), Belgium (##), Denmark (##), Germany (##), France (##), Italy (##), Greece (##), Coratia (##), Poland (##), Spain (##), Czech Republic (##) and

  • Chronic Disease
  • Vitamin
  • World
  • Market Size
  • Clinigen Group plc
  • KEY MARKET HIGHLIGHTS
  • GLOBAL CHEMOTHERAPY-INDUCED NEUROPATHIC PAIN DRUGS MARKET 2016-2021 ($ MILLIONS)

In one study, ##% topical lidocaine applied as a patch is successful in treating diabetic neuropathy as oral pregabalin, posting around ##% favorable response rate.

  • Chronic Disease
  • Vitamin
  • Depomed, Inc.
  • Eli Lilly & Co.
  • Endo International plc

Recommended first line-treatments are antidepressants (tricyclic antidepressants and dual reuptake inhibitors of both serotonin and norepinephrine), Ca+ pregabalin), and topical lidocaine.

  • Chronic Disease
  • United States
  • World
  • Merck & Co., Inc.
  • Pfizer Inc.

IT IS A NEXT-GENERATION LIDOCAINE PATCH THAT DELIVERS BIOEQUIVALENT LEVELS OF LIDOCAINE UPON APPLICATION AT THE SITE OF PAIN.

  • Chronic Disease
  • Vitamin
  • North America
  • United States
  • Eli Lilly & Co.
  • APPROVED AND LATE-STAGE DRUGS FOR NEUROPATHIC PAIN
  • 4.1.7 SUBSTANTIAL IMPACT OF CHRONIC PAIN IN THE U.S.

The other important products include Lidocaine Patch, Fentanyl, and Oxymorphone.

  • Chronic Disease
  • United States
  • Egalet Corporation
  • Pfizer Inc.
  • Purdue Pharma L.P.

Note: Dietary Supplements: Brand Ranking by Positioning 2016 IMMUNE SYSTEM BRAND RANKING ## ## ## ## ## ## PHARMATON SA NBTY INC MERCK KGAA HEALTHAID LTD NBTY INC NBTY INC BRAND COLLAGEN PRO-ACTIVE MY ELEMENTS BEAUTIN COLLAGEN SOLGAR SKIN, AGE AND HAIR HEALTHAID OSTEOFLEX SOLGAR GLUCOSAM

  • Vitamin
  • Greece
  • Hellas SA
  • Pfizer Inc.
  • Vitabiotics Ltd
  • Target
  • Clinical Trial profile. 145 Trial Title

Boehringer Sohn AG & Co KG Reckitt Benckiser Group Plc ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## GlaxoSmithKline Plc ## ## ## ## ## ## ## Tris Pharma Inc Ligand Pharmaceuticals Inc ## ## ## ## ## ## ## ## ## ## ## ## ## ## Bayer AG

  • Chronic Disease
  • Clinical Trial
  • Vitamin
  • World
  • Merck & Co., Inc.
  • 5. All the trials included are unique trials.

Boehringer Sohn AG & Co KG ## ## ## ## ## ## Allergan Plc ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## Marksans Pharma Ltd ## ## ## ## ## ## Lotus Labs Pvt Ltd ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## Bayer AG ## ## ## ## ## ## lidocaine alone or in combi

  • Chronic Disease
  • Pharmaceutical
  • Vitamin
  • World
  • Product Initiative
  • LOW BACK PAIN - PIPELINE BY IMMUNE PHARMACEUTICALS INC, H1 2018
  • LOW BACK PAIN - PIPELINE BY GRUNENTHAL GMBH, H1 2018

Phase II trial of a sterile lidocaine patch trademarked by EpiCept as LidoPAIN SP.

  • Chronic Disease
  • Chronic Pain
  • Vitamin
  • United States
  • Product Initiative
  • 5. All the trials included are unique trials.

## ## India ## ## ## ## ## ## ## ## Russia ## ## ## ## ## ## ## ## Brazil ## ## ## ## ## ## ## ## Mexico ## ## ## ## ## ## ## ## Turkey Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • World
  • Pfizer Inc.
  • lidocaine alone or in combination has the highest number of visceral pain ongoing clinical trials.
  • VISCERAL PAIN THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018*

The prominent features of this report are - ##.

  • Chronic Disease
  • Chronic Pain
  • Pharmaceutical
  • Vitamin
  • World

TENSION -TYPE HEADACHE THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* TENSION -TYPE HEADACHE THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* acetaminophen and lidocaine alone or in combination has the highest number of tension -type headache ongoing

  • Chronic Disease
  • OTC
  • Salicylic Acid
  • World
  • Product Initiative
  • Clinical Trial profile. 147 Trial Title
  • Clinical Trial profile. 169 Trial Title

The prominent features of this report are - ##.

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • China
  • World
  • LOW BACK PAIN - PIPELINE BY IMMUNE PHARMACEUTICALS INC, H2 2019
  • LOW BACK PAIN - PIPELINE BY SCILEX HOLDING CO, H2 2019

Phase II trial of a sterile lidocaine patch trademarked by EpiCept as LidoPAIN SP.

  • Chronic Disease
  • Chronic Pain
  • Therapy
  • United States
  • Product Initiative
  • MYALGIA (MUSCLE PAIN) THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2019*
  • TOP COMPANIES PARTICIPATING IN MYALGIA (MUSCLE PAIN) THERAPEUTICS CLINICAL TRIALS

lidocaine ## diclofenac ## paclitaxel ## celecoxib ## carbamazepine ## botulinum toxinA ## Total ## CLINICAL TRIAL PROFILE SNAPSHOTS Note: ##.

  • Chronic Disease
  • Musculoskeletal Disorder
  • Therapy
  • Vitamin
  • World
  • Clinical Trial profile. 204 Trial Title
  • Clinical Trial profile. 96 Trial Title

The prominent features of this report are - ##.

  • Chronic Disease
  • Clinical Trial
  • Pharmaceutical
  • Vitamin
  • World
  • Clinical Trial profile. 27 Trial Title
  • Clinical Trial profile. 32 Trial Title

The prominent features of this report are - ##.

  • Chronic Disease
  • Chronic Pain
  • Pharmaceutical
  • Vitamin
  • World
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Chronic Disease
  • Drug Development
  • Respiratory Disease
  • China
  • World
  • Clinical Trial profile. 173 Trial Title
  • Clinical Trial profile. 546 Trial Title

The prominent features of this report are - ##.

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Vitamin
  • World
  • Clinical Trial profile. 45 Trial Title
  • Clinical Trial profile. 256 Trial Title

The prominent features of this report are - ##.

  • Chronic Disease
  • Drug Development
  • Vitamin
  • World
  • Pfizer Inc.
  • Clinical Trial profile. 17 Trial Title
  • CLINICAL TRIAL PROFILE SNAPSHOTS

The prominent features of this report are - ##.

  • Chronic Disease
  • Therapy
  • World
  • Product Initiative
  • Gilead Sciences, Inc.
  • Target
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Chronic Disease
  • Hypertension
  • Pharmaceutical
  • Vitamin
  • World
  • LIDOCAINE ALONE OR IN COMBINATION HAS THE HIGHEST NUMBER OF NEUROPATHIC PAIN ONGOING CLINICAL TRIALS.
  • Clinical Trial profile. 1045 Trial Title

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Vitamin
  • Pfizer Inc.
  • Clinical Trial profile. 814 Trial Title
  • Clinical Trial profile. 368 Trial Title

The prominent features of this report are - ##.

  • Chronic Disease
  • Chronic Pain
  • Vitamin
  • World
  • Pain Therapeutics
  • Clinical Trial profile. 217 Trial Title
  • Clinical Trial profile. 732 Trial Title

The prominent features of this report are - ##.

  • Chronic Disease
  • Opioid
  • Vitamin
  • World
  • Pfizer Inc.

The prominent features of this report are - ##.

  • Anti Rheumatic
  • Chronic Disease
  • Vitamin
  • World
  • Product Initiative

A Randomized Double-blind Clinical Trial Comparison of Anesthetic Efficacy of ##% Articaine and ##% Lidocaine for Maxillary Buccal Infiltration in Patients with Irreversible Pulpitis.

  • Chronic Disease
  • Clinical Trial
  • Pharmaceutical
  • Vitamin
  • World
  • Clinical Trial profile. 118 Trial Title

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Chronic Disease
  • Drug Development
  • Vitamin
  • World
  • Product Initiative